BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Borren NZ, Ghadermarzi S, Hutfless S, Ananthakrishnan AN. The emergence of Clostridium difficile infection in Asia: A systematic review and meta-analysis of incidence and impact. PLoS One 2017;12:e0176797. [PMID: 28463987 DOI: 10.1371/journal.pone.0176797] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 8.8] [Reference Citation Analysis]
Number Citing Articles
1 Althaqafi A, Munshi A, Baghlaf B, Munshi E, Malakah M, Almarhabi H, Alharbi M, Alsaedi A. The prevalence, risk factors, and complications of Clostridium difficile infection in a tertiary care center, western region, Saudi Arabia. J Infect Public Health 2022;15:1037-42. [PMID: 36041381 DOI: 10.1016/j.jiph.2022.08.009] [Reference Citation Analysis]
2 Tan C, Zhu F, Xiao Y, Wu Y, Meng X, Liu S, Liu T, Chen S, Zhou J, Li C, Wu A. Immunoinformatics Approach Toward the Introduction of a Novel Multi-Epitope Vaccine Against Clostridium difficile. Front Immunol 2022;13:887061. [PMID: 35720363 DOI: 10.3389/fimmu.2022.887061] [Reference Citation Analysis]
3 Kunishima H, Ohge H, Suzuki H, Nakamura A, Matsumoto K, Mikamo H, Mori N, Morinaga Y, Yanagihara K, Yamagishi Y, Yoshizawa S. Japanese Clinical Practice Guidelines for Management of Clostridioides (Clostridium) difficile infection. J Infect Chemother 2022:S1341-321X(21)00347-0. [PMID: 35618618 DOI: 10.1016/j.jiac.2021.12.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Liu X, Shrestha R, Koju P, Maharjan B, Shah P, Thapa P, Li H. The direct medical economic burden of healthcare-associated infections and antimicrobial resistance: A preliminary study in a teaching hospital of Nepal. J Glob Antimicrob Resist 2022:S2213-7165(22)00093-5. [PMID: 35483612 DOI: 10.1016/j.jgar.2022.04.016] [Reference Citation Analysis]
5 Dilnessa T, Getaneh A, Hailu W, Moges F, Gelaw B. Prevalence and antimicrobial resistance pattern of Clostridium difficile among hospitalized diarrheal patients: A systematic review and meta-analysis. PLoS ONE 2022;17:e0262597. [DOI: 10.1371/journal.pone.0262597] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Monaghan TM, Biswas R, Satav A, Ambalkar S, Kashyap RS. Mini-review: Clostridioides difficile epidemiology in India. Anaerobe 2022. [DOI: 10.1016/j.anaerobe.2022.102517] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Mehrotra T, Maulik SK. Hepatic drug metabolism and gut microbiome. Progress in Molecular Biology and Translational Science 2022. [DOI: 10.1016/bs.pmbts.2022.07.005] [Reference Citation Analysis]
8 Gupta A, Savanti F, Singh B, Sachdev P, Raj D, Garg I, Aruwani SK, Shaukat F. Risk Factors Associated With Clostridium difficile-Associated Diarrhea. Cureus 2021;13:e18115. [PMID: 34692326 DOI: 10.7759/cureus.18115] [Reference Citation Analysis]
9 Ahn SW, Lee SH, Kim UJ, Jang HC, Choi HJ, Choy HE, Kang SJ, Roh SW. Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection. Gut Pathog 2021;13:55. [PMID: 34530913 DOI: 10.1186/s13099-021-00451-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Nana T, Moore C, Boyles T, Brink AJ, Cleghorn J, Devenish LM, du Toit B, Fredericks ES, Lekalakala-Mokaba MR, Maluleka C, Rajabally MN, Reubenson G, Shuping L, Swart K, Swe Han KS, Wadula J, Wojno J, Lowman W. South African Society of Clinical Microbiology Clostridioides difficile infection diagnosis, management and infection prevention and control guideline. S Afr J Infect Dis 2020;35:219. [PMID: 34485483 DOI: 10.4102/sajid.v35i1.219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Esfandiari Z, Amani F, Khavari S, Sami M. Clostridioides difficile in Non-hospital Sources (Animals, Food, and Environment) in Asian Countries: A Literature Review. Jundishapur J Microbiol 2021;14. [DOI: 10.5812/jjm.115347] [Reference Citation Analysis]
12 Wongkuna S, Janvilisri T, Phanchana M, Harnvoravongchai P, Aroonnual A, Aimjongjun S, Malaisri N, Chankhamhaengdecha S. Temporal Variations in Patterns of Clostridioides difficile Strain Diversity and Antibiotic Resistance in Thailand. Antibiotics (Basel) 2021;10:714. [PMID: 34199301 DOI: 10.3390/antibiotics10060714] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Abad CLR, Safdar N. A Review of Clostridioides difficile Infection and Antibiotic-Associated Diarrhea. Gastroenterol Clin North Am 2021;50:323-40. [PMID: 34024444 DOI: 10.1016/j.gtc.2021.02.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
14 Saber T, Hawash YA, Ismail KA, Khalifa AS, Alsharif KF, Alghamdi SA, Saber T, Eed EM. Prevalence, toxin gene profile, genotypes and antibiotic susceptibility of Clostridium difficile in a tertiary care hospital in Taif, Saudi Arabia. Indian J Med Microbiol 2020;38:176-82. [PMID: 32883931 DOI: 10.4103/ijmm.IJMM_20_300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ghia CJ, Waghela S, Rambhad GS. Systematic Literature Review on Burden of Clostridioides difficile Infection in India. Clin Pathol 2021;14:2632010X211013816. [PMID: 34104883 DOI: 10.1177/2632010X211013816] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Gupta A, Ananthakrishnan AN. Economic burden and cost-effectiveness of therapies for Clostridiodes difficile infection: a narrative review. Therap Adv Gastroenterol 2021;14:17562848211018654. [PMID: 34104214 DOI: 10.1177/17562848211018654] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
17 AlJindan R, AlEraky DM, Borgio JF, AbdulAzeez S, Abdalhamid B, Mahmoud N, Farhat M. Diagnostic deficiencies of C. difficile infection among patients in a tertiary hospital in Saudi Arabia: A laboratory-based case series. Saudi J Biol Sci 2021;28:4472-7. [PMID: 34354432 DOI: 10.1016/j.sjbs.2021.04.044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Han E, Lee S, Jekarl DW, Ji J. Correlation Between Fecal Toxin Enzyme Immunoassays and Disease Severity in Patients with Clostridioides difficile Infection in a Korean University Hospital. Lab Med Online 2021;11:124-131. [DOI: 10.47429/lmo.2021.11.2.124] [Reference Citation Analysis]
19 Czepiel J, Krutova M, Mizrahi A, Khanafer N, Enoch DA, Patyi M, Deptuła A, Agodi A, Nuvials X, Pituch H, Wójcik-Bugajska M, Filipczak-Bryniarska I, Brzozowski B, Krzanowski M, Konturek K, Fedewicz M, Michalak M, Monpierre L, Vanhems P, Gouliouris T, Jurczyszyn A, Goldman-Mazur S, Wultańska D, Kuijper EJ, Skupień J, Biesiada G, Garlicki A. Mortality Following Clostridioides difficile Infection in Europe: A Retrospective Multicenter Case-Control Study. Antibiotics (Basel) 2021;10:299. [PMID: 33805755 DOI: 10.3390/antibiotics10030299] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
20 Shokoohizadeh L, Alvandi F, Yadegar A, Azimirad M, Hashemi SH, Alikhani MY. Frequency of toxin genes and antibiotic resistance pattern of Clostridioides difficile isolates in diarrheal samples among hospitalized patients in Hamadan, Iran. Gastroenterol Hepatol Bed Bench 2021;14:165-73. [PMID: 33968344] [Reference Citation Analysis]
21 Zhang VRY, Woo ASJ, Scaduto C, Cruz MTK, Tan YY, Du H, Feng M, Siah KTH. Systematic review on the definition and predictors of severe Clostridiodes difficile infection. J Gastroenterol Hepatol 2021;36:89-104. [PMID: 32424877 DOI: 10.1111/jgh.15102] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
22 Goyal M, Hauben L, Pouseele H, Jaillard M, De Bruyne K, van Belkum A, Goering R. Retrospective Definition of Clostridioides difficile PCR Ribotypes on the Basis of Whole Genome Polymorphisms: A Proof of Principle Study. Diagnostics (Basel) 2020;10:E1078. [PMID: 33322677 DOI: 10.3390/diagnostics10121078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Dai W, Yang T, Yan L, Niu S, Zhang C, Sun J, Wang Z, Xia Y. Characteristics of Clostridium difficile isolates and the burden of hospital-acquired Clostridium difficile infection in a tertiary teaching hospital in Chongqing, Southwest China. BMC Infect Dis 2020;20:277. [DOI: 10.1186/s12879-020-05014-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
24 Brodzicki A, Jaworek-Korjakowska J, Kleczek P, Garland M, Bogyo M. Pre-Trained Deep Convolutional Neural Network for Clostridioides Difficile Bacteria Cytotoxicity Classification Based on Fluorescence Images. Sensors (Basel) 2020;20:E6713. [PMID: 33255305 DOI: 10.3390/s20236713] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
25 Mondal SI, Draper LA, Ross RP, Hill C. Bacteriophage endolysins as a potential weapon to combat Clostridioides difficile infection. Gut Microbes 2020;12:1813533. [PMID: 32985336 DOI: 10.1080/19490976.2020.1813533] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
26 Chaudhary J, Deepinder K C, Singh Chhina R, Kaur Sandhar T. A study of Clostridium difficile positivity using multistep algorithm of testings in a tertiary care hospital. IJMMTD 2020;6:165-169. [DOI: 10.18231/j.ijmmtd.2020.037] [Reference Citation Analysis]
27 Doll M, Marra AR, Apisarnthanarak A, Al-Maani AS, Abbas S, Rosenthal VD. Prevention of Clostridioides difficile in hospitals: A position paper of the International Society for Infectious Diseases. Int J Infect Dis 2021;102:188-95. [PMID: 33122100 DOI: 10.1016/j.ijid.2020.10.039] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
28 Odoyo E, Kyanya C, Mutai W, Musila L. High levels of toxigenic Clostridioides difficile contamination of hospital environments: a hidden threat in hospital-acquired infections in Kenya. Access Microbiol 2020;2:acmi000171. [PMID: 33490867 DOI: 10.1099/acmi.0.000171] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
29 Shah HB, Smith K, Scott EJ 2nd, Larabee JL, James JA, Ballard JD, Lang ML. Human C. difficile toxin-specific memory B cell repertoires encode poorly neutralizing antibodies. JCI Insight 2020;5:138137. [PMID: 32663199 DOI: 10.1172/jci.insight.138137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
30 Lew T, Putsathit P, Sohn KM, Wu Y, Ouchi K, Ishii Y, Tateda K, Riley TV, Collins DA. Antimicrobial Susceptibilities of Clostridium difficile Isolates from 12 Asia-Pacific Countries in 2014 and 2015. Antimicrob Agents Chemother 2020;64:e00296-20. [PMID: 32393487 DOI: 10.1128/AAC.00296-20] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
31 Nakao S, Hasegawa S, Shimada K, Mukai R, Tanaka M, Matsumoto K, Uranishi H, Masuta M, Ikesue H, Hashida T, Iguchi K, Nakamura M. Evaluation of anti-infective-related Clostridium difficile-associated colitis using the Japanese Adverse Drug Event Report database. Int J Med Sci 2020;17:921-30. [PMID: 32308545 DOI: 10.7150/ijms.43789] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
32 Kimura T, Stanhope S, Sugitani T. Clostridioides (Clostridium) difficile infection in Japanese hospitals 2008-2017: A real-world nationwide analysis of treatment pattern, incidence and testing density. J Infect Chemother 2020;26:438-43. [PMID: 32081648 DOI: 10.1016/j.jiac.2019.11.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
33 Mi H, Bao R, Xiao Y, Cui Y, Sun W, Shen Y, Shi Q, Chen X, Lin J, Hu B, Gao X. Colonization of Toxigenic Clostridium difficile Among Intensive Care Unit Patients: A Multi-Centre Cross-Sectional Study. Front Cell Infect Microbiol 2020;10:12. [PMID: 32083021 DOI: 10.3389/fcimb.2020.00012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
34 Luo Y, Cheong E, Bian Q, Collins DA, Ye J, Shin JH, Yam WC, Takata T, Song X, Wang X, Kamboj M, Gottlieb T, Jiang J, Riley TV, Tang YW, Jin D. Different molecular characteristics and antimicrobial resistance profiles of Clostridium difficile in the Asia-Pacific region. Emerg Microbes Infect 2019;8:1553-62. [PMID: 31662120 DOI: 10.1080/22221751.2019.1682472] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
35 Ananthakrishnan AN, Xavier RJ. Gastrointestinal Diseases. Hunter's Tropical Medicine and Emerging Infectious Diseases 2020. [DOI: 10.1016/b978-0-323-55512-8.00003-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
36 Chiang HY, Huang HC, Chung CW, Yeh YC, Chen YC, Tien N, Lin HS, Ho MW, Kuo CC. Risk prediction for 30-day mortality among patients with Clostridium difficile infections: a retrospective cohort study. Antimicrob Resist Infect Control 2019;8:175. [PMID: 31749963 DOI: 10.1186/s13756-019-0642-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
37 Tay HL, Chow A, Ng TM, Lye DC. Risk factors and treatment outcomes of severe Clostridioides difficile infection in Singapore. Sci Rep 2019;9:13440. [PMID: 31530847 DOI: 10.1038/s41598-019-49794-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
38 Malekzadegan Y, Halaji M, Hasannejad-Bibalan M, Jalalifar S, Fathi J, Ebrahim-Saraie HS. Burden of Clostridium (Clostridioides) difficile Infection among Patients in Western Asia: A Systematic Review and Meta-Analysis. Iran J Public Health 2019;48:1589-99. [PMID: 31700814] [Reference Citation Analysis]
39 Sofjan AK, Islam MA, Halder K, Kabir ND, Saleh AA, Miranda J, Lancaster C, Begum K, Alam MJ, Garey KW. Molecular epidemiology of toxigenic Clostridioides difficile isolates from hospitalized patients and the hospital environment in Dhaka, Bangladesh. Anaerobe 2020;61:102081. [PMID: 31356958 DOI: 10.1016/j.anaerobe.2019.102081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Thorpe CM, McDermott LA, Tran MK, Chang J, Jenkins SG, Goldstein EJC, Patel R, Forbes BA, Johnson S, Gerding DN, Snydman DR. U.S.-Based National Surveillance for Fidaxomicin Susceptibility of Clostridioides difficile-Associated Diarrheal Isolates from 2013 to 2016. Antimicrob Agents Chemother 2019;63:e00391-19. [PMID: 31085514 DOI: 10.1128/AAC.00391-19] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
41 Lv X, Zhang J, Jiang M, Liu Y, Ren W, Fang Z. Clostridium difficile-associated diarrhea following the therapy with antibiotic and proton pump inhibitors in a 77-year-old man with several comorbidities: A case report. Medicine (Baltimore) 2019;98:e15004. [PMID: 30921218 DOI: 10.1097/MD.0000000000015004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
42 Zhou Y, Mao L, Yu J, Lin Q, Luo Y, Zhu X, Sun Z. Epidemiology of Clostridium difficile infection in hospitalized adults and the first isolation of C. difficile PCR ribotype 027 in central China. BMC Infect Dis 2019;19:232. [PMID: 30845918 DOI: 10.1186/s12879-019-3841-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
43 Balsells E, Shi T, Leese C, Lyell I, Burrows J, Wiuff C, Campbell H, Kyaw MH, Nair H. Global burden of Clostridium difficile infections: a systematic review and meta-analysis. J Glob Health 2019;9:010407. [PMID: 30603078 DOI: 10.7189/jogh.09.010407] [Cited by in Crossref: 81] [Cited by in F6Publishing: 95] [Article Influence: 20.3] [Reference Citation Analysis]
44 Curcio D, Cané A, Fernández FA, Correa J. Clostridium difficile-associated Diarrhea in Developing Countries: A Systematic Review and Meta-Analysis. Infect Dis Ther 2019;8:87-103. [PMID: 30659481 DOI: 10.1007/s40121-019-0231-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
45 Collins DA, Riley TV. Clostridium difficile in Asia: Opportunities for One Health Management. Trop Med Infect Dis 2018;4:E7. [PMID: 30597880 DOI: 10.3390/tropicalmed4010007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
46 Cho JC, Crotty MP, Pardo J. Ridinilazole: a novel antimicrobial for Clostridium difficile infection. Ann Gastroenterol 2019;32:134-40. [PMID: 30837785 DOI: 10.20524/aog.2018.0336] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
47 Ramai D, Zakhia K, Ofosu A, Ofori E, Reddy M. Fecal microbiota transplantation: donor relation, fresh or frozen, delivery methods, cost-effectiveness. Ann Gastroenterol 2019;32:30-8. [PMID: 30598589 DOI: 10.20524/aog.2018.0328] [Cited by in Crossref: 15] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
48 Hong W, Cheng Y, Rao F, Yang J, Cui G, Chen Z, Liao J, Huang X, Zhang J, Wang P, Wang S, Wang Y, Guan Z, Qi X. Co-infection of Clostridioides (Clostridium) difficile GMU1 and Bacillus cereus GMU2 in one patient in Guizhou, China. Anaerobe 2018;54:159-63. [PMID: 30273671 DOI: 10.1016/j.anaerobe.2018.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
49 Chang TH, Hsu WY, Yang TI, Lu CY, Hsueh PR, Chen JM, Lee PI, Huang LM, Chang LY. Increased age and proton pump inhibitors are associated with severe Clostridium difficile infections in children. J Microbiol Immunol Infect 2020;53:578-84. [PMID: 30287184 DOI: 10.1016/j.jmii.2018.09.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
50 Collins J, Danhof H, Britton RA. The role of trehalose in the global spread of epidemic Clostridium difficile. Gut Microbes 2019;10:204-9. [PMID: 30118389 DOI: 10.1080/19490976.2018.1491266] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
51 Hong W, Zhang J, Cui G, Wang L, Wang Y. Multiplexed CRISPR-Cpf1-Mediated Genome Editing in Clostridium difficile toward the Understanding of Pathogenesis of C. difficile Infection. ACS Synth Biol 2018;7:1588-600. [PMID: 29863336 DOI: 10.1021/acssynbio.8b00087] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 9.4] [Reference Citation Analysis]
52 Nasiri MJ, Goudarzi M, Hajikhani B, Ghazi M, Goudarzi H, Pouriran R. Clostridioides (Clostridium) difficile infection in hospitalized patients with antibiotic-associated diarrhea: A systematic review and meta-analysis. Anaerobe 2018;50:32-7. [DOI: 10.1016/j.anaerobe.2018.01.011] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
53 Roldan GA, Cui AX, Pollock NR. Assessing the Burden of Clostridium difficile Infection in Low- and Middle-Income Countries. J Clin Microbiol 2018;56:e01747-17. [PMID: 29305541 DOI: 10.1128/JCM.01747-17] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
54 Maida M, Mcilroy J, Ianiro G, Cammarota G. Faecal Microbiota Transplantation as Emerging Treatment in European Countries. Adv Exp Med Biol 2018;1050:177-95. [PMID: 29383670 DOI: 10.1007/978-3-319-72799-8_11] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
55 Heinrich K, Harnett J, Vietri J, Chambers R, Yu H, Zilberberg M. Impaired Quality of Life, Work, and Activities Among Adults with Clostridium difficile Infection: A Multinational Survey. Dig Dis Sci 2018;63:2864-73. [PMID: 30074110 DOI: 10.1007/s10620-018-5222-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
56 Chow VCY, Kwong TNY, So EWM, Ho YII, Wong SH, Lai RWM, Chan RCY. Surveillance of antibiotic resistance among common Clostridium difficile ribotypes in Hong Kong. Sci Rep 2017;7:17218. [PMID: 29222426 DOI: 10.1038/s41598-017-17523-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
57 Verbeke F, Janssens Y, Wynendaele E, De Spiegeleer B. Faecal microbiota transplantation: a regulatory hurdle? BMC Gastroenterol 2017;17:128. [PMID: 29179687 DOI: 10.1186/s12876-017-0687-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
58 Khan MA, Hays JP, Elabbasy MT, Al-mogbel MS. Rise of Clostridium difficile infections: an overview. Reviews in Medical Microbiology 2017;28:152-157. [DOI: 10.1097/mrm.0000000000000111] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
59 Chaudhry R, Sharma N, Gupta N, Kant K, Bahadur T, Shende TM, Kumar L, Kabra SK. Nagging Presence of Clostridium difficile Associated Diarrhoea in North India. J Clin Diagn Res 2017;11:DC06-9. [PMID: 29207702 DOI: 10.7860/JCDR/2017/29096.10592] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]